[
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Co. stock underperforms Friday when compared to competitors",
    "summary": "Bristol Myers Squibb Co. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=6802f068a62760d56ea29255ce08ab422fafd697f296527d448cd1be80e1c127",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755880680,
      "headline": "Bristol Myers Squibb Co. stock underperforms Friday when compared to competitors",
      "id": 136492077,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Bristol Myers Squibb Co. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=6802f068a62760d56ea29255ce08ab422fafd697f296527d448cd1be80e1c127"
    }
  },
  {
    "ts": null,
    "headline": "BMY vs GSK: Which Biopharma Bigwig Has Better Prospects for Now?",
    "summary": "Bristol Myers leans on new launches to offset legacy drug declines, while GSK's diverse portfolio and strong HIV lineup keep growth on track.",
    "url": "https://finnhub.io/api/news?id=85402f41c44218585009f5c5a1416b3cdd45b657d03573d790aa0b3220be0244",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755875460,
      "headline": "BMY vs GSK: Which Biopharma Bigwig Has Better Prospects for Now?",
      "id": 136478336,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol Myers leans on new launches to offset legacy drug declines, while GSK's diverse portfolio and strong HIV lineup keep growth on track.",
      "url": "https://finnhub.io/api/news?id=85402f41c44218585009f5c5a1416b3cdd45b657d03573d790aa0b3220be0244"
    }
  },
  {
    "ts": null,
    "headline": "BNY Mellon Income Stock Fund Q2 2025 Commentary",
    "summary": "BNY Mellon Income Stock Fund returned 4.52% during the second quarter of 2025. Click here to read more.",
    "url": "https://finnhub.io/api/news?id=23f57fa4f5db9e26acfa435cac2f2e51ea2c778ce0c77e630a64c2e73ef2dea0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755860400,
      "headline": "BNY Mellon Income Stock Fund Q2 2025 Commentary",
      "id": 136476513,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2187991365/image_2187991365.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "BNY Mellon Income Stock Fund returned 4.52% during the second quarter of 2025. Click here to read more.",
      "url": "https://finnhub.io/api/news?id=23f57fa4f5db9e26acfa435cac2f2e51ea2c778ce0c77e630a64c2e73ef2dea0"
    }
  }
]